ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31

Enveric Biosciences, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$1.39+0.01 (+0.72%)

Close on Oct 19, 2026

Market cap: $5.54M
P/E (TTM): –
Dividend yield: –

Enveric Biosciences, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Cash & Equivalents	4.68	2.24	2.29	18	17	1.58	0.04	0.11	4.88	1.38	1.88	1.38	0.00	0.00	0.02	0.00	0.00
Short-Term Investments	–	–	–	–	–	–	–	–	–	0.08	–	–	–	–	–	–	–
Cash & Short-Term Investments	4.68	2.24	2.29	18	17	1.58	0.04	0.11	4.88	1.46	1.88	1.38	0.00	0.00	0.02	0.00	0.00
Receivables	–	–	–	–	–	–	6.38	7.87	8.84	8.06	4.87	–	–	–	–	–	–
Prepaid Expenses & Other	0.26	0.49	1.29	0.71	0.38	0.70	0.07	–	–	–	–	–	–	–	–	–	–
Other Current Assets	–	–	–	–	–	–	0.78	0.82	0.92	0.63	0.34	–	0.00	0.00	0.00	–	–
Total Current Assets	4.94	2.73	3.58	18	18	2.28	0.11	10	15	10	7.18	0.01	0.00	0.01	0.02	0.00	–
Property, Plant & Equipment	0.16	0.31	0.51	0.68	0.29	–	0.08	0.06	0.10	0.10	0.07	–	–	–	–	–	–
Accumulated Depreciation	-0.68	-0.49	-0.36	-0.18	-0.03	0	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	–	–	–	0.06	0.18	–	0.29	0.37	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	0.38	1.59	–	14	14	22	17	3.47	–	–	–	–	–	–
Intangible Assets	–	0.04	0.21	0.38	0.55	1.82	0	5.78	9.47	8.76	3.11	–	–	–	–	–	–
Deferred Tax Assets	–	–	–	–	–	–	0.01	0.01	6.09	3.49	–	–	–	–	–	–	–
Total Assets	5.10	3.08	4.30	20	27	4.10	0.11	30	52	40	14	0.01	0.00	0.01	0.02	0.00	–
Accounts Payable	0.58	0.52	1.22	0.46	0.68	–	4.70	4.38	5.32	5.13	2.60	–	–	–	0.02	0.01	–
Accrued Expenses	0.24	0.74	1.08	1.71	1.29	–	–	–	–	–	–	–	–	–	–	–	–
Short-Term Debt	–	–	–	–	–	–	4.88	5.21	4.80	3.49	–	–	–	–	–	–	–
Current Portion of Long-Term Debt	–	–	–	–	–	–	–	0.01	0.75	0.41	–	–	–	–	–	–	–
Current Debt	–	–	–	–	–	–	4.88	5.21	5.55	3.49	1.24	–	–	–	–	–	–
Current Portion of Leases	–	–	–	0.06	0.11	–	0.12	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	0.26	0.02	–	–	–	0.65	0.18	0.45	0.53	0.32	–	–	–	–	–	–
Other Current Liabilities	0.10	0.23	0.02	0.85	–	–	0.24	0.28	0.39	0.57	1.09	–	–	–	–	–	–
Total Current Liabilities	0.92	1.49	2.34	4.00	2.74	0.68	14	15	30	13	8.58	0.01	0.02	0.03	0.02	0.05	–
Long-Term Debt	–	–	–	–	–	–	–	0	1.13	1.54	–	–	–	–	–	–	–
Long-Term Leases	–	–	–	–	0.07	–	0.17	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	–	–	–	0.06	0.18	–	0.29	0.37	–	–	–	–	–	–	–	–	–
Total Liabilities	0.92	1.49	2.34	4.00	4.41	0.68	1.92	19	33	28	14	0.01	0.02	0.03	0.02	0.05	–
Total Debt	–	–	–	–	–	–	4.88	5.21	6.68	5.03	1.24	–	–	–	–	–	–
Preferred Stock	–	–	–	–	–	0.03	0.00	0.00	0.00	0.00	–	–	–	–	–	–	–
Common Stock	0.01	0.00	0.00	0.02	0.01	0.10	0.05	0.02	0.18	0.14	0.12	0.15	0.12	0.12	0.12	0.07	–
Additional Paid-In Capital	120	108	101	94	83	15	3.04	45	34	15	1.19	47	47	47	47	47	–
Retained Earnings	-115	-106	-96	-79	-61	-12	-4.89	-34	-15	-3.83	-1.05	-47	-47	-47	-47	-47	–
Comprehensive Income & Other	-0.58	-0.59	-0.57	-0.54	-0.03	-0.18	-0.01	0.09	0.04	-0.01	–	–	–	–	–	–	–
Shareholders' Equity	4.18	1.59	1.96	15	22	3.42	-1.81	-0.07	19	12	0.26	0.00	-0.02	-0.02	0.00	-0.05	-0.01
Noncontrolling Interest	–	–	–	–	–	–	–	–	0	0.00	–	–	–	–	–	–	–
Total Equity	4.18	1.59	1.96	15	22	3.42	-1.81	-0.07	19	12	0.26	0.00	-0.02	-0.02	0.00	-0.05	-0.01
Total Liabilities & Equity	5.10	3.08	4.30	20	27	4.10	0.11	30	52	40	14	0.01	0.00	0.01	0.02	0.00	–
Shares Outstanding(shares)	1.06	0.06	0.18	2.08	0.65	0.20	0.11	0.03	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -304.0%

Financial strength

Current ratio: 10.21
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 963.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.69
Dividend yield: –